Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06890169 Sponsor: Changi General Hospital Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06890169
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an adult between 21 and 70 years old
  • Your Body Mass Index (BMI) — a measure of body weight relative to height — is above 27.5
  • Your waist measurement is greater than 90 cm (about 35.5 inches) if you are a man, or greater than 80 cm (about 31.5 inches) if you are a woman
  • You have either poorly controlled type 2 diabetes (with a blood sugar level called HbA1c above 6.5%), and/or a condition where fat has built up in the liver (confirmed by a scan or tissue sample), with no other long-term liver disease present

Who may not be able to join:

  • Men who regularly drink more than 21 units of alcohol per week, or women who drink more than 14 units per week
  • People who have previously taken medication specifically to help with weight loss — although if you are interested in joining, you may be able to participate after waiting at least 3 months since stopping that medication
  • People with a serious illness where life expectancy is estimated to be less than 6 months
  • People who are unable to read and follow written instructions provided in English

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joan Khoo, MBBS, FRCP, Changi General Hospital

Phone: +65 69365641

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changi General Hospital
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

weight loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov